VAERS reports by lot

Novartis Vaccines Meningococcal lot M7455: VAERS reports

32 VAERS reports list lot M7455 as a Novartis Vaccines Meningococcal vaccine, received between 2022-06-13 and 2023-09-01. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
32
Reports
0%
Marked serious
0
With a death outcome
11
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
General / Systemic (non-local)1629%
Musculoskeletal815%
Neurological713%
Dermatological (non-injection-site)611%
Cardiac / Cardiovascular59%
Allergic / Anaphylactic59%
Injection-site / Local reaction59%
Gastrointestinal35%

Where reports came from

U.S. state of the reporter, where given (top 12).

Michigan5
Georgia4
Illinois3
Texas3
Indiana2
Pennsylvania2
New York2
Minnesota2
Missouri1
Wisconsin1
Oregon1
Florida1

Reports by month received

2022-065
2022-078
2022-084
2022-101
2022-111
2023-014
2023-023
2023-041
2023-052
2023-082
2023-091

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.